Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kewaunee Scientific (KEQU) EBT Margin (2016 - 2026)

Kewaunee Scientific has reported EBT Margin over the past 17 years, most recently at 2.31% for Q1 2026.

  • Quarterly results put EBT Margin at 2.31% for Q1 2026, up 41.0% from a year ago — trailing twelve months through Jan 2026 was 5.6% (up 152.0% YoY), and the annual figure for FY2025 was 6.15%, down 29.0%.
  • EBT Margin for Q1 2026 was 2.31% at Kewaunee Scientific, down from 4.93% in the prior quarter.
  • Over the last five years, EBT Margin for KEQU hit a ceiling of 9.61% in Q4 2023 and a floor of 2.18% in Q1 2022.
  • Median EBT Margin over the past 5 years was 4.72% (2022), compared with a mean of 4.35%.
  • Biggest five-year swings in EBT Margin: soared 877bps in 2023 and later crashed -562bps in 2025.
  • Kewaunee Scientific's EBT Margin stood at 0.84% in 2022, then skyrocketed by 1049bps to 9.61% in 2023, then fell by -14bps to 8.23% in 2024, then plummeted by -40bps to 4.93% in 2025, then tumbled by -53bps to 2.31% in 2026.
  • The last three reported values for EBT Margin were 2.31% (Q1 2026), 4.93% (Q4 2025), and 5.51% (Q3 2025) per Business Quant data.